Abstract
Objective: Determine the burden of illness associated with respiratory syncytial virus (RSV) and human metapneumovirus (HMPV) in adults, especially young adults.Design: Prospective surveillance study usingRT‐PCRfor the diagnosis ofRSVandHMPV.Setting: One academicEmergencyDepartment (ED), one academic hospital and three middleTennessee community hospitals.Sample: We prospectively enrolledMiddleTennessee residents ≥18 years old evaluated in the emergency department (ED) or hospitalized for respiratory symptoms May 2009 through April 2010. We collected nose/throat specimens forRSVandHMPVreverse‐transcriptase polymerase chain reaction (RT‐PCR) testing and obtained demographic and clinical data.Main outcome Measures: Rates ofEDvisits and hospitalizations were calculated using the proportion of enrolled patients positive for each virus multiplied by the number ofMiddleTennessee residents evaluated inEDs and/or hospitalized inTennessee for acute respiratory illness during the study period.Results: Three thousand two hundred and fifty six patients were eligible; 1477 (45·4%) were enrolled; 1248 (84·5%) of these consented to additional testing and had adequate samples.RT‐PCRidentified 32 (2·6%) patients withRSVand 33 (2·6%) withHMPV. The median duration of symptoms beforeEDpresentation was 3·3 days withRSVand 2·8 days withHMPV, and before hospital admission was 4·5 days withRSVand 3·5 days withHMPV. The annual hospitalization andEDvisit rates were similar forRSVandHMPV. The hospitalization rate associated with each virus was about 10 per 10 000 persons aged ≥50 years;EDrates were approximately 2 times higher. Hospitalization rates were about 2 per 10 000 persons aged 18–49 years, withEDrates 5–6 times higher.Conclusion: RSVandMPVare associated with substantial disease in adults, with hospitalization andEDvisits rates increasing with age.

This publication has 19 references indexed in Scilit: